The oncological product of a resident of the SEZ of Moscow received the national mark "Made in Russia"

The first domestic biosimilar of a drug for the treatment of head and neck cancer has received a "Made in Russia" certificate from the Russian Export Center. The innovative medicine, which is produced by Technopolis Moscow, a resident of the special economic zone (SEZ), is supplied to all regions of the country. This was announced by Maxim Liksutov, Deputy Mayor of Moscow for Transport and Industry.

"On behalf of Moscow Mayor Sergei Sobyanin, Russia's largest pharmaceutical cluster is being formed on the basis of the SEZ. 10 enterprises are already producing innovative broad-spectrum medicines here. The domestic drug for the treatment of oncological diseases has been awarded the "Made in Russia” certificate by the Russian Export Center in the “Reliability” category. The status obtained confirms that the products of the capital manufacturer comply with strict quality standards and guarantees that they will receive state support measures when promoting medicines to foreign markets," Maxim Liksutov said.

The Sputnik Technopolis plant, which is part of the R-Pharm group of companies, is engaged in the production of the drug. The drug belongs to the class of monoclonal antibodies, its action inhibits the growth of tumor cells and prevents the development of metastases. The full cycle of drug production, including the production of an active pharmaceutical substance, is implemented at the plant of a resident of the Moscow SEZ. Previously, the company had already mastered the production of other vital drugs. Among them are drugs for the treatment of a wide range of oncological and autoimmune diseases, including breast cancer, lymphoma, and rheumatoid arthritis.

The "Made in Russia" program is coordinated by the Russian Ministry of Industry and Trade, and the main functions of its implementation are assigned to the Russian Export Center. The program promotes domestic brands to foreign markets and guarantees the reliability of Russian manufacturers as suppliers of high-quality products. The corresponding certificate gives the right to apply a mark in the form of a bird in the colors of the Russian flag to the products. The products of the program participants are actively promoted abroad, primarily in the most promising and priority markets, including China and the Middle East.

Technopolis Moscow Special Economic Zone celebrates its 20th anniversary in 2026. Over two decades, the project has transformed from a launching pad for innovative projects into a key hub for the domestic industry and a center of attraction for companies that determine Russia's technological sovereignty. Today, the production of more than 250 high-tech enterprises representing such strategic areas as microelectronics, instrumentation, biomedicine, IT and robotics is localized at 10 sites of the Technopolis Moscow SEZ with a total area of 430 hectares.

Sergei Sobyanin declared October 2026 the month of Moscow industry. The program includes more than 25 events for businesses, students, young professionals, city residents and tourists. The capital will host the Moscow Investment and Industrial Forum, Career Day, the Dynasty Awards ceremony, as well as over 20 excursions to modern high-tech production sites and open educational lectures. For the first time, the city will host the International Forum of Special Economic Zones. Among his guests are partners from the BRICS countries, the EAEU and the Shanghai Cooperation Organization.

Moscow is actively developing industrial infrastructure for high-tech enterprises. Thanks to urban solutions, companies are increasing production and launching innovative productions. This contributes to the implementation of the national project "Efficient and Competitive Economy".